Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

12,272 total articles

ZenaTech’s ZenaDrone Prepares the IQ Quad Land Survey Drone for Submission for Blue UAS Certification to Enable U.S. Government and Defense Procurement Readiness

ZenaTech’s ZenaDrone Prepares the IQ Quad Land Survey Drone for Submission for Blue UAS Certification to Enable U.S. Government and Defense Procurement Readiness

ZenaTech, a Nasdaq-listed AI-focused drone technology company, announced that its U.S. subsidiary ZenaDrone is preparing to submit its IQ Quad land survey drone for Blue UAS certification by the U.S. Department of Defense. This certification enables compliance with the National Defense Authorization Act (NDAA) and makes the IQ Quad eligible for pro…

Invivyd Announces Completion of Enrollment in Phase 3 LIBERTY Trial Evaluating VYD2311 Antibody Versus mRNA COVID-19 Vaccine

Invivyd Announces Completion of Enrollment in Phase 3 LIBERTY Trial Evaluating VYD2311 Antibody Versus mRNA COVID-19 Vaccine

Invivyd, Inc. announced completion of enrollment for their Phase 3 LIBERTY clinical trial evaluating the safety, tolerability, and immune response of their investigational COVID-19 monoclonal antibody VYD2311 compared to mRNA COVID-19 vaccines, including co-administration effects. The trial is part of Invivyd's broader REVOLUTION clinical program t…

SD Government announces Federal Aviation Administration STC approval for Gogo Galileo HDX installation on the Pilatus PC-12

SD Government announces Federal Aviation Administration STC approval for Gogo Galileo HDX installation on the Pilatus PC-12

Gogo Inc.'s government-focused subsidiary, SD Government, in partnership with Pilatus and Pro Star Aviation, has received FAA Supplemental Type Certificate approval to install the Gogo Galileo HDX connectivity system on the Pilatus PC-12 turboprop. This enables high-speed, low-latency global satellite connectivity for government, defense, and speci…

Aya Gold & Silver Added to the VanEck Gold Miners ETF (GDX)

Aya Gold & Silver Added to the VanEck Gold Miners ETF (GDX)

Aya Gold & Silver Inc., a Canadian precious metals mining company with operations in Morocco, announced its inclusion in the VanEck Gold Miners ETF (GDX) effective June 19, 2026. This milestone reflects the company's recent growth achievements and is expected to enhance the stock's liquidity and visibility among a global investor base.

HCW Biologics Announces Positive Results for Preliminary Human Data Readout for Phase 1 Clinical Trial Evaluating IL-2 Based Fusion Immunotherapeutic, HCW9302 Monotherapy, in Alopecia Areata

HCW Biologics Announces Positive Results for Preliminary Human Data Readout for Phase 1 Clinical Trial Evaluating IL-2 Based Fusion Immunotherapeutic, HCW9302 Monotherapy, in Alopecia Areata

HCW Biologics announced encouraging preliminary results from its Phase 1 dose-escalation clinical trial evaluating HCW9302, an IL-2 based fusion immunotherapeutic, in patients with alopecia areata. All participants in the second dose cohort (3 mcg/kg) showed clinical improvement in hair loss severity scores with good tolerability and no severe side…

AMD and Rackspace Technology Sign Definitive Agreement for Phased Deployment of  30 MW of AMD AI Compute

AMD and Rackspace Technology Sign Definitive Agreement for Phased Deployment of 30 MW of AMD AI Compute

AMD and Rackspace Technology have signed a definitive agreement to deploy 30 MW of AMD-based AI compute infrastructure across Rackspace's global data centers from late 2026 through 2028. This partnership aims to deliver a governed AI stack focused on regulated industries, combining AMD's AI-optimized CPUs and GPUs with Rackspace's enterprise AI clo…

Pasithea Therapeutics Announces Amendments to Clinical Study Protocol for Phase 1/1B NF1 Clinical Trial

Pasithea Therapeutics Announces Amendments to Clinical Study Protocol for Phase 1/1B NF1 Clinical Trial

Pasithea Therapeutics announced amendments to its Phase 1/1b clinical trial protocol for PAS-004 in neurofibromatosis type 1 (NF1) patients. The changes include additional higher dose levels (24mg and 32mg), the ability to backfill prior cohorts, extended treatment periods up to 18 months, and enhanced imaging and tumor measurement methods. These a…

Verizon Breaks Industry Mold to Put Customers First

Verizon Breaks Industry Mold to Put Customers First

Verizon Communications announced a major customer-focused transformation including an industry-first loyalty program rewarding all customers with Verizon Dollars, the elimination of device activation and upgrade fees, a new simple and affordable Simplicity plan offering premium 5G access for all customers, and the Verizon One converged plan combini…

NovaBridge Biosciences Receives FDA Fast Track Designation for Givastomig in First-Line HER2-Negative Metastatic Gastric Cancer

NovaBridge Biosciences Receives FDA Fast Track Designation for Givastomig in First-Line HER2-Negative Metastatic Gastric Cancer

NovaBridge Biosciences announced that the FDA has granted Fast Track Designation to givastomig, a novel bispecific antibody, combined with nivolumab and chemotherapy for treating patients with previously untreated HER2-negative advanced or metastatic gastroesophageal adenocarcinomas. This designation is expected to accelerate the development and re…

embecta appoints Nimish Muzumdar as SVP and President, North America

embecta appoints Nimish Muzumdar as SVP and President, North America

embecta Corp. has appointed Nimish Muzumdar as Senior Vice President and President of North America, effective June 15, 2026. Mr. Muzumdar brings extensive leadership experience from the generic pharmaceuticals sector and will lead commercial efforts in the US and Canada to drive long-term growth as embecta broadens its portfolio beyond insulin del…